Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dalfó

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Neuroscience Letters|April 28, 2005
Alpha-synuclein binding to rab3a in multiple system atrophyE Dalfó, I Ferrer
Neuroscience Letters|February 8, 2007
Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's diseaseI Ferrer, E Perez, E Dalfó, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 21, 2007
Glycolitic enzymes are targets of oxidation in aged human frontal cortex and oxidative damage of these proteins is increased in progressive supranuclear palsyA Martínez, E Dalfó, G Muntané, et al.
Neurobiology of Aging|November 29, 2005
Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob diseaseM Freixes, A Rodríguez, E Dalfó, et al.
Neuroscience|March 18, 2008
Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathiesG Muntané, E Dalfó, A Martinez, et al.
Brain Pathology (Zurich, Switzerland)|December 21, 2004
Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactionsE Dalfó, J L Albasanz, M Martin, et al.
Acta Neuropathologica|April 5, 2003
Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemiaI Ferrer, B Friguls, E Dalfó, et al.
Neuropathology and Applied Neurobiology|September 26, 2003
Caspase-dependent and caspase-independent signalling of apoptosis in the penumbra following middle cerebral artery occlusion in the adult ratI Ferrer, B Friguls, E Dalfó, et al.
Neurobiology of Disease|June 23, 2004
Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body diseaseE Dalfó, M Barrachina, J L Rosa, et al.
Biochimica Et Biophysica Acta|July 25, 2003
Activation of human lung semicarbazide sensitive amine oxidase by a low molecular weight component present in human plasmaE Dalfó, M Hernandez, J M Lizcano, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Neuroscience Letters|April 28, 2005
Alpha-synuclein binding to rab3a in multiple system atrophyE Dalfó, I Ferrer
Neuroscience Letters|February 8, 2007
Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's diseaseI Ferrer, E Perez, E Dalfó, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 21, 2007
Glycolitic enzymes are targets of oxidation in aged human frontal cortex and oxidative damage of these proteins is increased in progressive supranuclear palsyA Martínez, E Dalfó, G Muntané, et al.
Neurobiology of Aging|November 29, 2005
Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob diseaseM Freixes, A Rodríguez, E Dalfó, et al.
Neuroscience|March 18, 2008
Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathiesG Muntané, E Dalfó, A Martinez, et al.
Brain Pathology (Zurich, Switzerland)|December 21, 2004
Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactionsE Dalfó, J L Albasanz, M Martin, et al.
Acta Neuropathologica|April 5, 2003
Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemiaI Ferrer, B Friguls, E Dalfó, et al.
Neuropathology and Applied Neurobiology|September 26, 2003
Caspase-dependent and caspase-independent signalling of apoptosis in the penumbra following middle cerebral artery occlusion in the adult ratI Ferrer, B Friguls, E Dalfó, et al.
Neurobiology of Disease|June 23, 2004
Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body diseaseE Dalfó, M Barrachina, J L Rosa, et al.
Biochimica Et Biophysica Acta|July 25, 2003
Activation of human lung semicarbazide sensitive amine oxidase by a low molecular weight component present in human plasmaE Dalfó, M Hernandez, J M Lizcano, et al.
Pageof 2